## 

## 

|CONTENTS||Page|
|---|---|---|
|Legal and administrative|information||
|Trustees'<br>report||2 —20|
|Independent<br>Auditor's|report|21-23|
|Consolidated<br>statement|offinancial activities|24|
|Charity and Group balance sheets||25|
|Consolidated<br>statement|ofcash flows|26|
|Notes to the financial statements||27-44|





|REGISTERED NAME OF CHARITY|StWilfrid's Hospice (Eastbourne)|StWilfrid's Hospice (Eastbourne)||
|---|---|---|---|
|CHARITY NUMBER|283686|||
|COMPANY NUMBER|1594410|||
|PRINCIPAL OFFICE/REGISTERED OFFICE|1 Broadwater<br>Way|||
||Eastbourne|||
||East Sussex|||
||BN22 9PZ|||
|PRESIDENT|Her Majesty The Queen Consort|||
|PATRONS|His Grace the Duke ofDevonshire<br>KCVO, CBE|||
||Mr David Dimbleby|||
||Dr Joan Hester|||
|TRUSTEES|Mr S O' Leary (appointed<br>on|28 September 2021)(Chair Irom||
||1 January 2022)|||
||Ms FMacIntyre<br>(Chair until|31December 2021)||
||Mr D Adams|||
||Dr M Barnes|||
||Mr A Breeze (retired 28 September 2021)|||
||Mrs JButler|||
||Ms LChambers|||
||Dr JMcGowan (retired 22 March 2022)|||
||Mr G Meyer|||
||Mrs VMorrey (retired 28 September 2021)|||
||Mrs KPlanterose<br>(retired 28|September 2021)||
||Mrs M Richardson|||
||Mr D Turner|||
|CHIEF EXECUTIVE|Mr D Scott-Ralphs|||
|LEADERSHIP TEAM||||
||Mr D Barclay (Medical Director)|||
||Mr CTwomey (Clinical Services Director)|||
||Ms A Dechamps<br>(Patient k, Family Support Director)|||
||Mrs PRussell (Development|Director)||
||Ms Vinyo Aidam (Finance and ITDirector -appointed||1April|
||2021,retired 8 April 2022)|||
||MrDMackenzie (Finance and ITDirector —appointed||8 April|
||2022)|||
|PROFESSIONAL ADVISORS|Haysmacintyre<br>LLP|||
||10Queen Street Place|||
||London|||
||EC4R 1AG|||





## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 


## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 



## 

## 

## 


## 

## 



## 


## 

## 

## 




## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 




## 

## 

## 

|Risk identified|||Actions taken to mitigate the risk||
|---|---|---|---|---|
|Uncertainty ofincome|and impact on cashflow.||Income<br>generation<br>strategy<br>focuses|on|
||||diversification<br>of<br>funding<br>streams.||
||||Establishment<br>oflegacy equalisation<br>reserve and||
||||increase<br>to 9 months<br>of free reserves<br>target.||
||||Rolling 3 year financial<br>and scenario planning.||
||||Quarterly I&Ereforecasts and 12month forward||
||||rolling<br>cash<br>flow<br>updated<br>monthly.<br>Active||
||||exploration<br>of opportunities<br>for cost sharing||
||||with<br>other hospices.<br>Continue<br>to engage<br>with||
||||ICB around<br>commissioning<br>and funding ofend||
||||oflife care.||
|Staffing capacity and resilience.|||Active workforce planning<br>to anticipate<br>future||
||||need and develop career pathways.<br>Additional||
||||medical resource budgeted<br>in 2022/23. Major||
||||focus on employee<br>and volunteer<br>wellbeing||
||||support.<br>Continuing<br>to recruit new volunteers.||
||||Improvements<br>to ITsystem to allow more||
||||efficient working. Diversity<br>audit leading to||
||||actions to broaden recruitment<br>reach.||
|Safeguarding.|||Safeguarding<br>Steering Group meets quarterly|to|
||||oversee work.<br>Corporate<br>safeguarding<br>risk||
||||register in place and featured<br>in every||
||||departmental<br>register. Mandatory<br>training<br>in||
||||children<br>and adult safeguarding<br>for clinical and||
||||non-clinical<br>staff and volunteers —over 90%||
||||completion.<br>Freedom to Speak Up Advocates|in|
||||place.||
|Major incident/business|continuity.||Major incident and recovery plan updated||
||||annually,<br>with test exercises undertaken.<br>IT||
||||system upgraded<br>to facilitate mobile working.||
||||Daily backups ofkey databases. Flu and Covid||
||||jabs offered to all staff. Focus on infection||
||||control. Regular fire drills and fire risk||
||||assessment.||
|||13|||





## 

|Cost ofrepairing|Cost ofrepairing|or replacing|fixed assets.|Fixed asset register in place. 15year asset|
|---|---|---|---|---|
|||||management<br>plan created (next review 2023)|
|||||and asset management<br>reserve being built.|
|||||Dilapidations<br>provision made for shops.|
|||||Fundraising<br>for capital works.|
|Fraud, theft|and|cyber crime.||Cyber Essentials Plus accreditation<br>achieved.|
|||||New IThardware<br>protected by Trend business|
|||||security and data encrypted<br>in the event ofloss.|
|||||Servers patched regularly<br>to provide updated|
|||||protection<br>against ransomware.<br>Electronic|
|||||payments<br>double signed by the leadership<br>team.|
|||||Annual cyber awareness<br>mandatory<br>training.|
|Information|governance.|||CEO is Senior Information<br>Risk Officer|
|||||(SIRO).Data Protection Steering Group|
|||||comprising<br>Information<br>Asset Owners meets|
|||||monthly.<br>Cyber Essentials Plus accreditation.|
|||||Privacy Impact Assessments<br>for each new|
|||||contract/initiative.<br>Annual ref'iesher training.|
|||||Sentinel AINM system facilitates reporting<br>and|
|||||monitoring<br>ofdata breaches.|



## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

|The Trustees who served during the year and their|attendance|at Board meet|ings<br>were:||||
|---|---|---|---|---|---|---|
||||||Meetings|attended|
|Mr S O' Leary<br>Chair ofTrustees (appointed<br>28 September <br>Ms FMacIntyre 4 "Chair ofthe People Committee<br>Mr D Adams¹||2021,as Chair|1 January|2022)|||
|Dr M Barnes 4|||||||
|Mr ABreezet<br>(retired 28 September 2021)|||||||
|Mrs JButler 4 Chair ofthe Clinical Governance|Committee|and Trustee Safeguarding||Lead|||
|Ms LChambers t<br>Ms JMcGowan 4 (retired 22March 2022)<br>Mr GMeyer¹|||||||
|Mrs VMorrey<br>(retired 28 September 2021)|||||||
|Mrs KPlanterose<br>~1(retired 28 September 2021)<br>Ms M Richardson iChair ofthe Audit Committee<br>Mr DTurner I¹Chair ofthe Income Generation<br>Committee|||||||



|Ms M Richardson iC<br>Mr DTurner I¹Chai|hair ofthe A<br>r ofthe Inco|
|---|---|
|Members ofTrustee|Committees:|
|t Audit Committee<br>4Clinical Governance<br>¹Income Generation|Committee<br>Committee|
|~ People Committee||



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 



## 

## 



## 

## 

||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|
||||Funds|Funds|2022|2021|
|||Notes|||||
|INCOME FROM:|||||||
|Donations<br>and legacies||2|4,220,215|453,563|4,673,778|5,543,781|
|Donated goods income||2,3||||3,352|
|Charitable<br>activities|||||||
|Statutory<br>funding<br>and grants||2|2,212,651|453,998|2,666,649|4,197,697|
|Other trading<br>activities|||||||
|Income f'rom trading||2,3|1,135,044||1,135,044|475,161|
|Income from lottery|||362,300||362,300|320,003|
|Investments|||60,763||60,763|34,221|
|Other|||21,767||21,767|138,108|
|Total income|||8,012,740|907,561|8,920,301|10,712,323|
|EXPENDITURE ON:|||||||
|Raising funds|||||||
|Fundraising<br>costs||6|956,854|22,254|979,108|959,275|
|Trading costs ofgoods|sold and||||||
|other costs||3|968,999||968,999|877,390|
|Charitable<br>activities|||||||
|In patient||6|2,944,318|759,025|3,703,343|3,931,650|
|Wellbeing||6|345,713|95,656|441,369|575,564|
|Community<br>Nursing||6|1,924,610|287,143|2,211,753|1,717,095|
|Total expenditure|||7,140,494|1,164,078|8,304,572|8,060,974|
|Net income/(expenditure)|before||||||
|net gains on investments|||872,246|(256,517)|615,729|2,651,349|
|Net gains on investments||13|253,288||253,288||
|Net income/(expenditure)|||1,125,534|(256,517)|869,017|2,651,349|
|Gross transfers between|funds|19|||||
|Net movement<br>in funds|||1,125,534|(256,517)|869,017|2,651,349|
|Fund balances at 1 April|2021||18,557,066|351,247|18,908,313|16,256,964|
|Fund balances at31March 2022||20,21|19,682,600|94,730|19,777,330|18,908,313|





## 

|||Hospice|Hospice|Group||
|---|---|---|---|---|---|
|||2022|2021|2022|2021|
||Notes|||||
|FIXEDASSETS||||||
|Tangible assets|12|9,817,946|10,033,577|9,817,946|10,034,035|
|Investments|13|4,334,859|857,509|4,334,758|857,408|
|||14,152,805|10,891,086|14,152,704|10,891,443|
|CURRENT ASSETS||||||
|Stocks||8,805|9,528|12,882|15,663|
|Debtors|14|3,265,614|3,662,258|3,191,652|3,661,839|
|Cash at bank and in hand||3,912,202|5,911,805|4,005,285|5,916,077|
|||7,186,621|9,583,591|7,209,819|9,593,579|
|CREDITORS: amounts||||||
|falling due within one year|15|(1,563,332)|(1,561,965)|(1,585,193)|(1,576,707)|
|NET CURRENT ASSETS||5,563,289|8,021,626|5,564,626|8,016,872|
|TOTAL ASSETSLESS||||||
|CURRENT LIABILITIES||19,776,094|18,912,712|19,777,330|18,908,313|
|NET ASSETS||19,776,094|18,912,712|19,777,330|18,908,313|
|FUNDS:||||||
|Restricted funds|18|94,730|351,247|94,730|351,247|
|Unrestricted<br>funds:||||||
|Designated<br>funds|19|14,217,535|14,169,340|14,217,535|14,169,340|
|Operating<br>reserve|19|5,463,829|4,392,125|5,465,065|4,387,726|
|||19,776,094|18,912,712|19,777,330|18,908,313|



## 



## 

## 

||||||||2022|2021|
|---|---|---|---|---|---|---|---|---|
|||||||Note|||
|Cash flows from operating||activities:|||||||
|Net cash provided<br>by operating<br>activities||||||21|1,458,545|1,689,073|
|Cash flows from investing||activities:|||||||
|Dividends,<br>interest and rents||&om investments|||||60,763|34,221|
|Proceeds &om the sale ofplant and equipment|||||||170|3,574|
|Purchase ofproperty,<br>plant|and equipment||||||(205,975)|(281,111)|
|Transfer ofinvestments|||||||(724,295)|(47,791)|
|Purchase ofinvestments|||||||(2,500,000)||
|Net cash (used in) investing||activities|||||(3,369,338)|(291,107)|
|Change in cash and cash equivalents|||in the reporting|period|||(1,910,792)|1,397,966|
|Cash and cash equivalents|at the beginning ofthe reporting||||period||5,916,077|4,518,111|
|Cash and cash equivalents||at the end|ofthe reporting|period|||4,005,285|5,916,077|





## 

|1.|ACCOUNTING<br>POLICIES|
|---|---|
||The principal<br>accounting<br>policies adopted, judgements<br>and key sources ofjudgement,<br>estimation<br>and uncertainty|
||in the preparation ofthe financial statements<br>are as follows:|
|1.1|Statement ofcompliance|
||The financial statements<br>have been prepared<br>in accordance with Accounting<br>and Reporting<br>by Charities:|
||Statement ofRecommended<br>Practice applicable to charities preparing<br>their accounts in accordance with the|
||Financial Reporting<br>Standard<br>applicable<br>in the UK and Republic ofIreland (FRS 102) - (Charities SORP Second|
||Edition, effective<br>1 January 2019),the Financial Reporting<br>Standard<br>applicable<br>in the UK and Republic of|
||Ireland (FRS 102)and the Companies<br>Act 2006.|
||StWil&id's Hospice (Eastbourne)<br>meets the definition ofapublic benefit entity under FRS 102.Assets and|
||liabilities are initially recognised athistorical cost or transaction<br>value unless otherwise<br>stated in the relevant|
||accounting policy note(s).|
|1.2|General information|
||The charity is aprivate company<br>limited by guarantee,<br>incorporated<br>in England and Wales (company number:|
||01594410)and a charity in England<br>and Wales (charity number: 283686).The charity's registered office is 1|
||Broadwater way, Eastbourne,<br>East Sussex, BN22 9PZ.|
|1.3|Preparation<br>ofaccounts on a going concern basis|
||At the time ofapproving<br>the financial statements,<br>Trustees have areasonable<br>expectation<br>that the charity has|
||adequate resources to continue<br>in operational<br>existence for the foreseeable future. In addition,<br>through|
||appropriate<br>consideration<br>ofrisks as part ofits normal risk management<br>processes and mitigating<br>actions both|
||already taken and available to be taken, the Trustees consider there are no material uncertainties<br>about the|
||Charity's<br>ability to continue as agoing concern.<br>The review ofthe Charity's<br>financial position, reserves levels|
||and future plans gives Trustees confidence the Charity remains agoing concern for the foreseeable<br>future.|
|1.4|Group financial statements|
||The financial statements<br>consolidate<br>the results ofthe charity and its wholly owned subsidiary<br>StWil&id's|
||Hospice Eastbourne<br>Trading Company<br>Limited (registered number: 02198239).The results ofthe wholly owned|
||subsidiary,<br>StWilfrid's<br>Hospice (Eastbourne)<br>Projects Limited, has not been consolidated<br>into these financial|
||statements<br>as its results are immaterial<br>to the charity and group. A separate Statement ofFinancial Activities and|
||Income and Expenditure<br>Account for the charity has not been presented<br>because the charity has taken advantage|
||ofthe exemption<br>afforded by section 408ofthe Companies Act 2006.The registered once for these subsidiaries|
||is the same as the parent.|
||Theconsolidated statement offinancial activities, income and expenditure<br>account and balance sheet include the|
||financial statements ofthe company<br>and its subsidiary<br>undertaking<br>made up to31March 2021.The company|
||has taken advantage<br>ofthe exemption<br>from presenting<br>its own income and expenditure<br>account. The|
||suiplus ofthe company for the financial year amounted<br>to f863,385(2021:Surplus E2,665,931).All|
||intercompany<br>transactions<br>are eliminated<br>on consolidation.|





## 

## 

## 

## 



## 

||ACCOUNTING<br>POLICIES (continued)||||
|---|---|---|---|---|
|1.9|Financial instruments||||
||The charity only has financial assets and financial liabilities ofakind that qualify as basic financial|instruments.|||
||Basic financial instruments<br>are initially recognised<br>at transaction<br>value and subsequently<br>measured|at their|||
||settlement<br>value with the exception ofbank loans which are subsequently<br>measured<br>at amortised cost using the||||
||effective interest method.||||
|1.10|Investments||||
||Investments<br>are a form ofbasic financial instruments<br>and are initially shown in the financial statements|at market|||
||value. Movements<br>in the market values ofinvestments<br>are shown as unrealised<br>gains and losses in the|Statement||of|
||Financial Activities.||||
||Profits and losses on the realisation ofinvestments<br>are shown as realised gains and losses in the Statement of||||
||Financial Activities. Realised gains and losses on investments<br>are calculated between sales proceeds and their||||
||opening carrying values or their purchase<br>value ifacquired subsequent<br>to the first day ofthe financial|year.|||
||Unrealised<br>gains and losses are calculated as the difference between the fair value at the year end and|their carrying|||
||value. Realised and unrealised<br>investment<br>gains and losses are combined<br>in the Statement ofFinancial|Activities.|||
||Stock||||
||Stock consists ofpurchased<br>goods for resale. Stocks are valued at the lower ofcost and net realisable value.||||
||Items donated for resale or distribution<br>are not included<br>in the financial statements<br>until they are sold or||||
||distributed.||||
|1.12|Creditors and provisions||||
||Creditors<br>and provisions<br>are recognised<br>where the charity has apresent obligation<br>resulting<br>Irom apast event||that||
||will probably result in the transfer offunds to a third party and the amount due to settle the obligation can be||||
||measured<br>or estimated reliably. Creditors and provisions<br>are normally<br>recognised at their settlement|amount after|||
||allowing for any trade discounts<br>due||||
|1.13|Debtors||||
||Trade and other debtors are recognised at the settlement<br>amount due after any trade discount offered.||||
||Prepayments<br>are valued at the amount prepaid net ofany trade discounts<br>due.||||
|1.14|Cash at bank and in hand||||
||Cash at bank and cash in hand includes cash and short term highly liquid investments<br>with a short maturity of||||
||three months or less from the date ofacquisition<br>or opening ofthe deposit or similar account.||||
|1.15|Pensions||||
||The charity operates adefined contribution<br>pension scheme. Contributions<br>are charged in the accounts as they||||
||become payable inaccordance with the rules ofthe scheme.||||
|1.16|Donated goods||||
||The Trustees consider the valuation ofdonated goods for resale at the point ofreceipt is impractical,|due to the|||
||high volume oflow value items and the administrative<br>costs involved<br>in valuation.<br>Goods donated for resale are||||
||therefore recognised<br>in the accounts at the point ofsale.||||
|1.17|Fund accounting||||
||General funds are unrestricted<br>funds which are available for use at the discretion ofthe trustees<br>in furtherance|||of|
||the general objectives ofthe charity and which have not been designated<br>for other purposes.||||
||Designated<br>funds<br>compriseunrestricted<br>funds thathave<br>been set aside by the trustees<br>for particular|purposes.|The||
||aim and use ofeach designated<br>fund is set out inthe notes to the financial<br>statements.||||
||Restricted funds comprise<br>funds received for a specific expenditure<br>as specified by the donor. The aim and use|||of|
||each restricted<br>fund is set out in the notes to the financial statements.||||





## 

## 

## 

|DONATIONS, LEGACIES AND|Unrestricted|Restricted||
|---|---|---|---|
|STATUTORY FUNDING|Funds|Funds|2022|
|Donations<br>and gifts|1,326,496|453,563|1,780,059|
|Donated Goods Income||||
|Legacies receivable|2,893,719||2,893,719|
|Grants receivable for core activities|2,212,651|453,998|2,666,649|
||6,432,866|907,561|7,340,427|
|DONATIONS, LEGACIES AND|Unrestricted|Restricted||
|STATUTORY FUNDING|Funds|Funds|2021|
||(Restated)|(Restated)|(Restated)|
|Prior Year —2021||||
|Donations<br>and gifts|1,239,549|359,357|1,598,906|
|Donated Goods Income|3,352||3,352|
|Legacies receivable|3,944,875||3,944,875|
|Grants receivable for core activities|2,570,616|1,627,081|4,197,697|
||7,758,392|1,986,438|9,744,830|





## 

## 

|ACTIVITIES FOR GENERATING FUNDS||2022||2021||
|---|---|---|---|---|---|
|Trading income and costs||||||
|Trading income||||||
|Donated goods income|955,404|||451,707||
|Bought in goods income|37,951|||7,950||
|Street cafe incoine|73,273|||15,504||
|Other operating<br>income|68,416|||||
||||1,135,044||475,161|
|Trading expenses||||||
|Cost ofsales|29,734|||10,749||
|Street cafe costs|96,774|||75,399||
|Staffexpenses|414,547|||403,120||
|Property expenses|331,284|||299,672||
|Administration<br>expenses|73,295|||64,580||
|Dilapidations/Depreciation|23,365|||23,875||
||||968,999||877,395|
|Less interest received|(4)|||(5)||
||||968,995||877,390|
|Total (deficit)/surplus|||166,049||(402,22|
||||||9)|
|Number ofshops||||||





## 

## 

|4.|INVESTMENT INCOME - UNRESTRICTED|INVESTMENT INCOME - UNRESTRICTED|INVESTMENT INCOME - UNRESTRICTED|||2022|2021|
|---|---|---|---|---|---|---|---|
||Rental income &om|investment|properties|||26,746|23,210|
||Income &om listed investments|||||21,454||
||Interest receivable|||||12,563|11,011|
|||||||60,763|34,221|
|5.|OTHER INCOME|—UNRESTRICTED||||2022|2021|
||Education courses and recharges||||||12,002|
||Other income|||||21,767|126,106|
|||||||21,767|138,108|
|6.|TOTAL EXPENDITURE|||Other|Support|||
||||Staff|Direct|Costs|Total||
||||Costs|Costs|Allocation|2022||
||Charitable<br>expenditure|||||||
||Primary costs|||||||
||Inpatient||2,047,604|905,207|750,532|3,703,343||
||Wellbeing||165,371|96,293|179,705|441,369||
||Community<br>Nursing||1,280,845|307,226|623,682|2,211,753||
||||3,493,820|1,308,726|1,553,919|6,356,465||
||Costs ofgenerating|funds||||||
||Non-charitable<br>trading||414,547|554,452||968,999||
||Fundraising||504,306|337,381|137,421|979,108||
||||4,412,673|2,200,559|1,691,340|8,304,572||
||SUPPORT COSTS|||||2022||
|||||||Total||
||Support staff|||||1,030,212||
||Office|||||244,744||
||Premises<br>and utilities|||||391,772||
||Governance|||||24,612||
|||||||1,691,340||
||GOVERNANCE COSTS|||||||
||Legal and professional|||||878||
||Auditors'<br>remuneration|||||16,600||
|||||||17,478||





## 

## 

||||||Staff|Other|Support|Total|
|---|---|---|---|---|---|---|---|---|
|||||||Direct|Costs||
||||||Costs|Costs|Allocation|2021|
|Charitable|expenditure||||||||
|Primary costs|||||||||
|Inpatient|||||2,163,234|806,137|962,279|3,931,650|
|Wellbeing|||||324,848|106,162|144,554|575,564|
|Community||Nursing|||1,133,395|79,670|504,030|1,717,095|
||||||3,621,477|991,969|1,610,863|6,224,309|
|Costs ofgenerating||||funds|||||
|Non-charitable|||trading||403,120|474,270||877,390|
|Fundraising|||||376,863|414,546|167,866|959,275|
||||||4,401,460|1,880,785|1,778,729|8,060,974|
|SUPPORT|COSTS|||||||2021|
|||||||||Total|
|Support staff||||||||1,090,322|
|Office||||||||126,211|
|Premises and||utilities||||||544,718|
|Governance||||||||17,478|
|||||||||1,778,729|
|GOVERNANCE|||COSTS||||||
|Legal and professional||||||||878|
|Auditors'<br>remuneration||||||||16,600|
|||||||||17,478|





## 

## 

|NET INCOME/(EXPENDITURE)|2022|2021|
|---|---|---|
|Net income is stated after:|||
|Auditors'<br>remuneration|||
|Audit services|15,125|14,400|
|Non-audit<br>services|2,050|1,950|
|Depreciation|421,891|375,839|



## 

## 

||||||||Hospice and Group|Hospice and Group|
|---|---|---|---|---|---|---|---|---|
|EMPLOYEES|||||||2022|2021|
||||||||Number|Number|
|The average|monthly|number ofemployees||during||the year was:|||
|Inpatient|||||||71|69|
|Wellbeing|||||||17|15|
|Hospice at Home|||||||59|44|
|Support staff|||||||54|46|
|Fundraising|||||||13|12|
|Retail|||||||24|20|
||||||||238|206|
|The full time|equivalent||number ofemployees||at March was:||||
|Inpatient|||||||43|52|
|Wellbeing|||||||12|12|
|Hospice at Home|||||||30|31|
|Support staff|||||||40|34|
|Fundraising|||||||11|11|
|Retail|||||||19|18|
||||||||155|158|
|Employment|costs||||||||
|Wages and salaries|||||||4,575,402|4,640,058|
|National<br>insurance|||||||433,248|425,546|
|Pension costs|||||||436,738|418,995|
|Redundancy|costs|||||||7,183|
||||||||5,445,388|5,491,782|





## 

## 

## 

## 

## 

## 




## 

## 

|TANGIBLE FIXED|ASSETS||||||
|---|---|---|---|---|---|---|
|||||Fixtures|||
|Hospice|Land and|Computer|Plant and|And|Motor||
||Buildings|Equipment|equipment|Fittings|Vehicles|Total|
|Cost|||||||
|At 1 April 2021|11,061,022|541,936|124,108|810,688|86,904|12,624,658|
|Additions||92,535|34,511|78,930||205,975|
|Disposals||(119,951)|(5,491)|(160,600)||(286,042)|
|At 31March 2022|11,061,022|514,520|153,128|729,018|86,904|12,544,592|
|Depreciation|||||||
|At 1 April 2021|1,518,617|335,080|67,985|632,469|36,390|2,591,081|
|Charge for the year|202,120|107,385|33,399|64,306|14,223|421,433|
|On disposals||(117,764)|(5,507)|(162,597)||(285,868)|
|At 31March 2022|1,720,737|324,701|95,877|534,178|50,613|2,726,646|
|Net Book Value|||||||
|At 31March 2022|9,340,285|189,819|57,251|194,840|36,291|9,817,946|
|At 31March 2021|9,542,405|206,856|56,123|178,219|49,974|10,033,577|
|Group|||||||
|Cost|||||||
|At 1 April 2021|11,061,022|543,586|124,108|810,688|86,904|12,626,308|
|Additions||92,535|34,511|78,930||205,976|
|Disposais||(119,951)|(5,491)|(160,600)||(286,042)|
|At 31March 2022|11,061,022|516,170|153,128|729,018|86,904|12,546,242|
|Depreciation|||||||
|At 1 April 2021|1,518,617|336,272|67,985|632,469|36,930|2,592,273|
|Charge for the year|202,120|107,843|33,399|64,306|14,223|421,891|
|On disposals||(117,764)|(5,507)|(162,597)||(285,868)|
|At 31March 2022|1,720,737|326,351|95,877|534,178|51,153|2,728,296|
|Net Book Value|||||||
|At 31March 2022|9,340,285|189,819|57,251|194,840|35,751|9,817,946|
|At 31March 2021|9,542,405|207,314|56,123|178,219|49,974|10,034,033|





## 

## 

|13|FIXEDASSET|FIXEDASSET|INVESTMENTS|INVESTMENTS|- GROUP AND|- GROUP AND||||
|---|---|---|---|---|---|---|---|---|---|
||HOSPICE||||||Investment|Listed|Total|
||||||||Properties|Investments|Investments|
||Market value|at|1 April|2021|||753,278|104,130|857,408|
||Additions<br>at market value|||||||4,812,305|4,812,305|
||Disposals at cost||||||(3,278)|(1,787,487)|(1,790,765)|
||Revaluation||||||185,000|68,288|253,288|
||Movement<br>in|investment||cash||||202,522|202,522|
||Group Market||value|at 31|||935,000|3,399,758|4,334,758|
||March 2022|||||||||
||Investment<br>in subsidiaries|||||||||
||Share capital|||||||||
||.StWilfrid's|Hospice (Eastbourne)|||Projects Limited||||1|
||.StWilfrid's|Hospice Eastbourne|||Trading|Company|||100|
||Limited|||||||||
||Hospice Market||value|at 31|||||4,334,859|
||March 2022|||||||||
||Historical cost:|||||||||
||At 31March|2022|||||516,851|3,517,956|4,034,807|
||At 31March|2021|||||516,851||516,851|
|14.|DEBTORS||||||Hospice||Group|
|||||||2022|2021|2022|2021|
||Legacies|||||1,514,772|2,114,653|1,514,772|2,114,653|
||Trade debtors|||||1,027,240|874,818|1,029,038|870,607|
||Amounts<br>owed by group|||undertakings||81,652||||
||Prepayments|&accrued||income||640,491|621,956|646,384|622,285|
||Other debtors|||||1,459|50,831|1,459|54,294|
|||||||3,265,614|3,662,258|3,191,652|3,661,839|





## 

## 

|15.|CREDITORS: amounts|falling due||Hospice||Group||
|---|---|---|---|---|---|---|---|
||within one year||2022|2021|2022||2021|
||Trade creditors||318,752|222,795|325,497||234,522|
||Taxes and social security|costs|27,054|103,614|28,025||103,614|
||Other creditors||174,923|115,616|174,923||115,616|
||Accruals||61,395|197,971|75,540||200,986|
||Deferred income||981,208|921,969|981,208||921,969|
||||1,563,332|1,561,965|1,585,193||1,576,707|



## 

## 



## 




## 

## 

|Prior Year Restricted|funds|funds|Balance at|Movement|in funds|Balance at|
|---|---|---|---|---|---|---|
||||1April|||31March|
||||2020|Income|Expenditure|2021|
|IPU Capital and Improving||Patient Care appeal|164,248|39,912|(45,548)|158,614|
|Hospice in the Community|||24,323|40,593|(30,556)|34,358|
|Wellbeing Appeal|||38,879|964|(8,878)|30,960|
|Minibus Appeal|||46,200||(5,021)|41,179|
|Spiritual Support Fund|||42,152||(37,674)|4,478|
|Garden Project|||20,559|1,000|(8,476)|13,083|
|Big Lottery Volunteers|Project||35,031|153,990|(154,960)|34,061|
|Bereavement<br>Help Point|||160|57,920|(47,794)|21,451|
|BBCChildren<br>In Need|Seahorse Project||8,158|38,049|(36,778)|9,429|
|Other Restricted Funds|||11,325|7,929|(8,089)||
|Bereavement||||6,000|(6,000)||
|Community<br>Bereavement||Project||13,000|(9,371)|3,629|
|COVID-19 Emergency|Response Funding|||1,627,081|(1,627,081)||
||||391,035|1,986,438|(2,026,226)|351,247|





## 

||||Balance at||Movement|Movement|in funds||Balance at|
|---|---|---|---|---|---|---|---|---|---|
||||1April||||||31March|
||||2021|Income|Expenditure||Gains/(losses)|Transfers|2022|
|Asset Management|Reserve||600,000|||||100,000|700,000|
|Legacy Equalisation|Reserve||2,560,177||||||2,560,177|
|Strategic Development||Reserve|975,130|||||(20,718)|954,412|
|Fixed Asset Reserve|||10,034,033|||||(216,087)|9,817,946|
|Revaluation<br>Reserve|||||||185,000||185,000|
|Designated<br>funds|||14,169,340||||185,000|(136,805)|14,217,535|
|General funds|||4,387,726|8,012,740|(7,140,494)||68,288|136,805|5,465,065|
|Total Unrestricted|Funds||18,557,066|8,012,740|(7,140,494)||253,288||19,682,600|
||||Balance at||Movement|in funds||Balance at||
||||1April|||||31March||
||||2020|Income|Expenditure||Transfers|2021||
|Asset Management|Reserve||300,000||||300,000|600,000||
|Legacy Equalisation|Reserve||960,177||||1,600,000|2,560,177||
|Strategic Development||Reserve|975,130|||||975,130||
|Fixed Asset Reserve|||10,130,622||||(96,589)|10,034,033||
|Designated<br>funds|||12,365,929||||1,803,411|14,169,340||
|General funds|||3,500,000|10,352,966|(7,661,829)||(1,803,411)|4,387,726||
|Total Unrestricted|Funds||15,865,929|10,352,966|(7,661,829)|||18,557,066||





## 

## 

|20.|ANALYSIS OFNETASSETSBETWEEN|ANALYSIS OFNETASSETSBETWEEN|ANALYSIS OFNETASSETSBETWEEN|General|Designated|Restricted||
|---|---|---|---|---|---|---|---|
||FUNDS|||Funds|Funds|Funds|Total|
||Fund balances at 31March 2022 are represented|||by:||||
||Tangible fixed assets||||9,817,946||9,817,946|
||Fixed Asset Investments|||4,334,758|||4,334,758|
||Current assets|||2,715,500|4,399,589|94,730|7,209,819|
||Creditors: amounts<br>falling due||within one year|(1,585,193)|||(1,585,193)|
|||||5,465,065|14,217,535|94,730|19,777,330|
||ANALYSIS OFNETASSETSBETWEEN|||General|Designated|Restricted||
||FUNDS —Prior Year|||Funds|Funds|Funds|Total|
||Fund balances at 31March 2021 are represented|||by:||||
||Tangible fixed assets||||10,034,033||10,034,033|
||Fixed Asset Investments|||857,408|||857,408|
||Current assets|||5,107,025|4,135,307|351,247|9,593,579|
||Creditors: amounts<br>falling due||within one year|(1,576,707)|||(1,576,707)|
|||||4,387,726|14,169,340|351,247|18,908,313|
|21.|RECONCILIATION|OFNET INCOME TO||||2022|2021|
||NET CASH FLOW FROM OPERATING ACTIVITIES|||||||
||Net income for the reporting||period (asper the|||||
||statement offinancial|activities)||||869,017|2,651,349|
||Adjustments<br>for:|||||||
||Depreciation<br>charges|||||421,891|375,839|
||Gains on invesnnents|||||(253,288)||
||Dividends,<br>interest and|rent &om investments||||(60,763)|(34,221)|
||(Profit)/loss<br>on the sale|offixed assets||||(170)|(1,712)|
||Decrease/(increase)<br>in|stocks||||2,781|(1,892)|
||Decrease/(increase)<br>in|debtors||||530,592|(1,543,465)|
||Increase/(decrease)<br>in creditors|||||8,486|(6,825)|
|||||42||||





## 

## 

||Changes<br>in assets|held for resale|||250,000|
|---|---|---|---|---|---|
||Net cash provided|by operating|activities|1,458,545|1,689,073|
|22.|OPERATING LEASES COMMITMENTS|||2022|2021|
||Group Leases which expire:|||||
||Within one year|||5,169|19,840|
||Within two to five|years|||5,169|
|||||5,169|25,509|
||Charity Leases which expire:|||||
||Within one year|||5,169|19,840|
||Within two to five|years|||5,169|
|||||5,169|25,509|






## 

## 

||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|
||Funds|Funds|2021|2020|
||(Restated)|(Restated)|(Restated)||
|INCOME FROM:|||||
|Donations<br>and legacies|5,184,424|359,357|5,543,781|4,655,873|
|Donated goods income|3,352||3,352|158,188|
|Charitable<br>activities|||||
|Statutory<br>funding<br>and grants|2,570,616|1,627,081|4,197,697|2,152,213|
|Other trading activities|||||
|Income &om trading|475,161||475,161|969,257|
|Income from lottery|320,003||320,003|314,910|
|Investments|34,221||34,221|56,882|
|Other|138,108||138,108|24,981|
|Total income|8,725,885|1,986,438|10,712,323|8,332,304|
|EXPENDITURE ON:|||||
|Raising funds|||||
|Fundraising<br>costs|954,974|4,301|959,275|882,830|
|Trading costs ofgoods sold and|||||
|other costs|877,390||877,390|977,547|
|Charitable<br>activities|||||
|In patient|2,232,734|1,698,916|3,931,650|3,717,979|
|Wellbeing|296,493|279,071|575,564|551,037|
|Community<br>Nursing|1,673,157|43,938|1,717,095|1,757,005|
|Total expenditure|6,034,748|2,026,226|8,060,974|7,886,398|
|Net gains/(losses)<br>on investments|||||
|Net income/(expenditure)|2,691,137|(39,788)|2,651,349|445,906|
|Gross transfers between funds|||||
|Net movement<br>in funds|2,691,137|(39,788)|2,651,349|445,906|
|Fund balances at 1 April 2020|15,865,929|391,035|16,256,964|15,811,058|
|Fund balances at31March 2021|18,557,066|351,247|18,908,313|16,256,964|



